Wednesday, August 10, 2022

Innovation: DRDO develops COVID-19 antibody detection kit ‘DIPCOVAN’

Must read

New Delhi: Defence Institute of Physiology and Allied Sciences (DIPAS), a laboratory of Defence Research and Development Organisation (DRDO), has developed an antibody detection-based kit 'DIPCOVAN', the DIPAS-VDx COVID-19 IgG Antibody Microwell ELISA for sero-surveillance. According to an official note, the DIPCOVAN kit can detect both spikes as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97 percent and specificity of 99 percent. The kit has been developed in association with Vanguard Diagnostics Pvt Ltd, a development and manufacturing diagnostics company based in New Delhi.

The COVID-19 antibody detection kit DIPCOVAN was developed indigenously by the scientists, followed by extensive validation on more than 1,000 patient samples at various COVID-19 designated hospitals in Delhi. Three batches of the product were validated during the last year. The antibody detection kit is approved by the Indian Council of Medical Research (ICMR) in April 2021.

In May 2021, the product received regulatory approval from the Drugs Controller General of India (DCGI), Central Drugs Standard Control Organisation (CDSCO), Ministry of Health and Family Welfare, to manufacture for sale and distribution.

ALSO READ:

1. BEML rolls out Mechanical mine field marking equipment MK-II

2. GRSE Financial Results: Net profit goes up by 18% to Rs 58 crore in Q4

"DIPCOVAN is intended for the qualitative detection of IgG antibodies in human serum or plasma, targeting SARS-CoV-2 related antigens. It offers a significantly faster turn-around-time as it requires just 75 minutes to conduct the test without any cross-reactivity with other diseases. The kit has a shelf life of 18 months. The kit will be very useful for understanding COVID‐19 epidemiology and assessing an individual's previous SARS‐CoV‐2 exposure," said a press release from the Ministry of Defence.

Industry partner Vanguard Diagnostics Pvt. Ltd will commercially launch the product during the first week of June 2021. Readily available stock at the time of launch will be 100 kits (approx. 10,000 tests) with a production capacity of 500 kits/month after the launch. It is expected to be available at about Rs 75 per test.

Defence Minister Rajnath Singh has appreciated the efforts of DRDO and the industry in developing the kit at the time of need.

Secretary Department of Defence R&D & Chairman DRDO Dr G Satheesh Reddy complimented the teams involved in developing the kit and said the initiative will help the people during the pandemic.

(PSU Watch– India's Business News centre that places the spotlight on PSUs, Bureaucracy, Defence and Public Policy is now on Google News. Click here to follow. Also, join PSU Watch Channel in your Telegram. You may also follow us on Twitter here and stay updated.)

- Advertisement -

More articles

- Advertisement -

Latest News